Clinical Trial Update: Sub Lingual Versus Traditional Oral Administration of Ticagrelor in Acute Coronary Syndrome/Non ST-elevation Myocardial Infarction - A Platelet Reactivity Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing sublingual versus traditional oral ticagrelor for platelet reactivity in acute coronary syndromes, including NSTEMI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Non-st-elevation Myocardial Infarction

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Sheba Medical Center | Conditions: Acute Coronary Syndromes, Non ST Elevation Myocardial Infarction | Phase 4 | Status: COMPLETED